Your browser doesn't support javascript.
loading
Variant in C-terminal region of intestinal alkaline phosphatase associated with benign familial hyperphosphatasaemia.
Ishige, Takayuki; Itoga, Sakae; Utsuno, Emi; Nishimura, Motoi; Yoshikawa, Masaharu; Kato, Naoya; Matsushita, Kazuyuki; Yokosuka, Osamu; Nomura, Fumio.
Afiliación
  • Ishige T; Division of Laboratory Medicine, Chiba University Hospital, Chiba, Japan.
  • Itoga S; Division of Laboratory Medicine, Chiba University Hospital, Chiba, Japan.
  • Utsuno E; Division of Clinical Genetics, Chiba University Hospital, Chiba, Japan.
  • Nishimura M; Division of Laboratory Medicine, Chiba University Hospital, Chiba, Japan.
  • Yoshikawa M; Division of Clinical Genetics, Chiba University Hospital, Chiba, Japan.
  • Kato N; Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Matsushita K; Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Yokosuka O; Division of Laboratory Medicine, Chiba University Hospital, Chiba, Japan.
  • Nomura F; Division of Clinical Genetics, Chiba University Hospital, Chiba, Japan.
J Med Genet ; 55(10): 701-704, 2018 10.
Article en En | MEDLINE | ID: mdl-29331981
BACKGROUND: A genetic diagnosis has been rarely performed in benign familial hyperphosphatasaemia, and molecular mechanism largely remains unclear. OBJECTIVES: We encountered a case with benign familial hyperphosphatasaemia of intestinal alkaline phosphatase (IAP). To elucidate the molecular mechanism, we performed ALPI gene sequencing and in vitro protein expression analysis. METHODS: ALPI gene was sequenced by long-range PCR and massively parallel sequencing. The soluble and membrane-bound ALP activities of the cultured cell line, transfected with the wild-type or variant-type ALPI gene were analysed by a glycosylphosphatidylinositol (GPI)-cleaving assay. RESULTS: We identified a deletion-insertion variant in the C-terminal end of the ALPI gene. This variant causes the attenuation of the hydrophobicity in GPI-anchor signal of IAP. An in vitro GPI-cleaving assay demonstrated that the membrane-bound IAP was greatly decreased, whereas the soluble IAP was increased, in the variant IAP. CONCLUSIONS: The C-terminal variant in ALPI causes the benign familial hyperphosphatasaemia of IAP by the attenuation of the membrane-binding capability.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Variación Genética / Fosfatasa Alcalina / Hiperfosfatemia Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Med Genet Año: 2018 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Variación Genética / Fosfatasa Alcalina / Hiperfosfatemia Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Med Genet Año: 2018 Tipo del documento: Article País de afiliación: Japón